144 related articles for article (PubMed ID: 32430698)
1. Antipsychotic Polypharmacy and High-Dose Antipsychotics in Involuntary Patients: a Seven-Year Audit of Discharge Prescriptions in an Acute Care Unit.
Martinho S; Poças A; Simões M; Laureano C
Psychiatr Q; 2021 Mar; 92(1):1-14. PubMed ID: 32430698
[TBL] [Abstract][Full Text] [Related]
2. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
3. Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.
Burness C; Corbet C; Beyene K; Webby C; Nankivell C; Cabasag P; Hari K; Fraser A; Gray S; Harrison J; Chan AHY
Psychiatry Res; 2021 Aug; 302():113996. PubMed ID: 34126462
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
[TBL] [Abstract][Full Text] [Related]
5. Patterns of antipsychotics' prescription in Portuguese acute psychiatric wards: A cross-sectional study.
Campos Mendes J; Azeredo-Lopes S; Cardoso G
Psychiatry Res; 2016 Dec; 246():142-148. PubMed ID: 27693867
[TBL] [Abstract][Full Text] [Related]
6. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
[TBL] [Abstract][Full Text] [Related]
7. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with antipsychotic polypharmacy and high-dose antipsychotics among individuals receiving compulsory treatment in the community.
Gisev N; Bell JS; Chen TF
J Clin Psychopharmacol; 2014 Jun; 34(3):307-12. PubMed ID: 24717256
[TBL] [Abstract][Full Text] [Related]
9. Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.
Kadra G; Stewart R; Shetty H; Jackson RG; Greenwood MA; Roberts A; Chang CK; MacCabe JH; Hayes RD
BMC Psychiatry; 2015 Jul; 15():166. PubMed ID: 26198696
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis.
Ayenew W; Asmamaw G; Bitew T
Int J Neuropsychopharmacol; 2021 Dec; 24(12):956-964. PubMed ID: 34245271
[TBL] [Abstract][Full Text] [Related]
11. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country.
Armstrong KS; Temmingh H
Braz J Psychiatry; 2017; 39(4):293-301. PubMed ID: 28177063
[TBL] [Abstract][Full Text] [Related]
13. Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.
Sneider B; Pristed SG; Correll CU; Nielsen J
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1669-76. PubMed ID: 26256007
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Concurrent Oral and Long-Acting Injectable Antipsychotic Prescribing at the Minneapolis Veterans Affairs Health Care System.
Dimitropoulos E; Drogemuller L; Wong K
J Clin Psychopharmacol; 2017 Oct; 37(5):605-608. PubMed ID: 28816923
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic Polypharmacy and High-Dose Antipsychotic Regimens in the Residential Italian Forensic Psychiatric Population (REMS).
Mandarelli G; Carabellese F; Di Sciascio G; Catanesi R
Front Psychol; 2022; 13():722985. PubMed ID: 35222172
[TBL] [Abstract][Full Text] [Related]
16. The Additional Effect of Individualized Prescriber-Focused Feedback on General Guideline Instruction in Reducing Antipsychotic Polypharmacy in Inpatients.
Lochmann van Bennekom MWH; Gijsman HJ; Groenewoud H; Verkes RJ
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):129-134. PubMed ID: 33666400
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021.
Lin CH; Huang CJ; Lin TC; Chan HY; Chen JJ
Psychiatry Res; 2023 Dec; 330():115575. PubMed ID: 37913621
[TBL] [Abstract][Full Text] [Related]
18. Prescription patterns in psychiatric compulsory care: polypharmacy and high-dose antipsychotics.
Kaikoushi K; Karanikola M; Middleton N; Bella E; Chatzittofis A
BJPsych Open; 2021 Aug; 7(5):e149. PubMed ID: 34747353
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
[TBL] [Abstract][Full Text] [Related]
20. Nationwide study on antipsychotic polypharmacy among forensic psychiatric patients.
Lassen S; Heintz T; Pedersen T; Jentz C; Nathanielsen N; Heilmann P; Sørensen LU
Int J Circumpolar Health; 2023 Dec; 82(1):2218654. PubMed ID: 37300837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
